A blend tested for 30 days
The double-blind, placebo-controlled trial assigned 100 adults aged 35 to 70 to two groups of 50 people. The active group received a combination of pea, rice and hemp proteins, along with ashwagandha and rhodiola, for 30 days.
Sleep was assessed daily using a questionnaire described as validated, the Sleep Quality Questionnaire. The researchers also measured phase angle using bioimpedance before and after the intervention. This is a measure separate from sleep, not an overnight recording.
Self-reported improvement, difficult to translate into a tangible benefit
The abstract reports a 58% improvement in the overall sleep score in the active group, along with reduced sleep difficulties and daytime sleepiness. The authors report a statistically greater improvement than with placebo.
This percentage does not mean that participants slept 58% longer. It refers to a questionnaire score. Without the absolute baseline and final scores for each group, it remains difficult to translate the finding into a tangible change for an individual.
Changes in phase angle were minimal in both groups. The trial therefore does not show a clear improvement in this other measured parameter.
Missing data complicate interpretation
Of the 100 people initially assigned to groups, 61 completed the sleep assessments: 32 in the active group and 29 in the placebo group. The abstract does not specify why these data were missing or provide enough detail on how they were handled statistically. This limits confidence in the size of the reported benefit.
The intervention combined several ingredients. Without groups testing the proteins, ashwagandha and rhodiola separately, it is impossible to determine which contributes to the result or whether combining them offers a particular advantage.
Safety remains insufficiently documented
No adverse events were reported, according to the abstract. However, this 30-day observation is not enough to establish long-term safety, possible interactions or tolerability in other populations.
The dossier contains only the PubMed abstract, not the full text. Funding, conflicts of interest, exclusion criteria and detailed procedures for monitoring adverse effects have not been verified.
Limitations to keep in mind
A 30-day study, sleep assessed by questionnaire, assessments completed by only 61 of the 100 participants, and no absolute scores in the abstract. The full text, funding and conflicts of interest have not been reviewed or verified.
What we can take away
This trial provides a favorable signal for self-reported sleep with a combined formula. It cannot isolate the effects of the herbs or establish a lasting benefit or well-established safety.
Sources and provenance
- Effects on Sleep Quality and Bioelectrical Parameters of Cellular Health After Administration of a Plant Protein Supplement Combined with Ashwagandha and Rhodiola: A Randomized Controlled Trial.
Source date: 2026-11-11.
Journal Article, Randomized Controlled Trial · Résumé PubMed uniquement, texte intégral non consulté


